Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (adderall XR) and atomoxetine (strattera) in school-aged children with ADHD

Journal of Attention Disorders

Volumn 11, Issue 1, 2007, Pages 74-82

  Faraone, Stephen V ^a   Wigal, Sharon B ^b   Hodgkins, Paul ^c  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Shire Development   (United States)

Author keywords

Adderall XR; Efficacy; Laboratory school; Strattera

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; AMPHETAMINE DERIVATIVE; ATOMOXETINE; CENTRAL STIMULANT AGENT; PROPYLAMINE; SLI381; UNCLASSIFIED DRUG;

ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; FOLLOW UP; FORECASTING; HUMAN; MALE; MULTICENTER STUDY; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINES; ATTENTION; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; PROBLEM SOLVING; PROPYLAMINES; TREATMENT OUTCOME; UNITED STATES;

EID: 34250746424     PISSN: 10870547     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087054706292196     Document Type: Article

References (15)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (text revision). Washington, DC: Author.
2. Biederman, J., Lopez, F.A., Boellner, S.W., Chandler, M.C. (2002). A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 in children with attention deficit hyperactivity disorder. Pediatrics, 110, 258-266.
3. Biederman, J., Quinn, D., Weiss, M., Markabi, S., Weidenman, K., Edson, K., et al. (2003). Efficacy and safety of Ritalin LA, a new, once-daily, extended-release dosage from of methylphenidate hydrochloride, in children with ADHD. Pediatric Drugs, 5, 833-841.
4. Claxton, A.J., Cramer, J., Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapy, 23, 1296-1310.
5. Greenhill, L.L., Findling, R.L., Swanson, J.M. (2002). A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics, 109, E39.
6. Greenhill, L.L., Halperin, J.M., Abikoff, H. (1999). Stimulant medications. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 503-512.
7. Hack, S., Chow, B. (2001). Pediatric psychotropic medication compliance: A literature review and research-based suggestions for improving treatment compliance. Journal of Child and Adolescent Psychopharmacology, 11, 59-67.
8. Kelsey, D.K., Sumner, C.R., Casat, C.D., Coury, D.L., Quintana, H., Saylor, K.E., et al. (2004). Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Pediatrics, 114, e1 - e8.
9. Michelson, D., Allen, A.J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., et al. (2002). Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized placebo-controlled study. American Journal of Psychiatry, 159, 1896-1901.
10. Swanson, J. (2003). Compliance with stimulants for attention-deficit/ hyperactivity disorder: Issues and approaches for improvement. CNS Drugs, 17, 117-131.
11. Swanson, J., Agler, D., Fineberg, E., Wigal, S., Flynn, D., Fineberg, K., et al. (1999). UCI laboratory school protocol for PK/PD studies. In L. L. Greenhill B. B. Osman (Eds.), Ritalin: Theory and practice (pp. 405-430). Larchmont, NY: Mary Ann Liebert.
12. Swanson, J., Wigal, S., Greenhill, L., Browne, R., Waslick, B., Lerner, M., et al. (1998). Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting. Psychopharmacology Bulletin, 34, 55-60.
13. Wigal, S., Gupta, S., Guinta, D., Swanson, J. (1998). Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacology Bulletin, 34, 47-53.
14. Wigal, S.B., Wigal, T.L., McGough, J.J., McCracken, J.T., Kollins, S.H., Biederman, J., et al. (2005). A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/ hyperactivity disorder. Journal of Attention Disorders, 9, 275-289.
15. Wolraich, M., Greenhill, L.L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., et al. (2001). Randomized controlled trial of OROS methylphenidate qd in children with Attention Deficit/Hyperactivity Disorder. Pediatrics, 108, 883-892.